New treatments for neovascular age-related macular degeneration: when should we use them?
Kvanta
Anders
A
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000628:therapy*; D002986:Clinical Trials as Topic; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008268:Macular Degeneration / Q000628:therapy*; D013508:Ophthalmologic Surgical Procedures; D017319:Photosensitizing Agents / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D005938:Glucocorticoids; D017319:Photosensitizing Agents